PT Pyridam Farma Tbk (PYFA.JK)
IDR 212.0
(0.95%)
IDR 212.0
(0.95%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 830.4 Billion IDR | 10.69% |
| 2022 | 750.23 Billion IDR | 106.79% |
| 2021 | 362.8 Billion IDR | 4430.54% |
| 2020 | 8 Billion IDR | 31.84% |
| 2019 | 6.07 Billion IDR | -9.01% |
| 2018 | 6.67 Billion IDR | 1203.32% |
| 2017 | 512.19 Million IDR | -40.19% |
| 2016 | 856.4 Million IDR | -79.17% |
| 2015 | 4.11 Billion IDR | -62.8% |
| 2014 | 11.05 Billion IDR | -39.34% |
| 2013 | 18.22 Billion IDR | 144.27% |
| 2012 | 7.45 Billion IDR | 441.67% |
| 2011 | 1.37 Billion IDR | 202.55% |
| 2010 | 455.18 Million IDR | 329.71% |
| 2009 | 105.92 Million IDR | 197.87% |
| 2008 | 35.56 Million IDR | -96.24% |
| 2007 | 947.03 Million IDR | -44.88% |
| 2006 | 1.71 Billion IDR | 267.22% |
| 2005 | 467.88 Million IDR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1232.64 Billion IDR | 47.58% |
| 2024 Q3 | 1671.1 Billion IDR | -2.89% |
| 2024 Q2 | 1720.84 Billion IDR | 40.42% |
| 2023 Q4 | 830.4 Billion IDR | -1.11% |
| 2023 Q1 | 747.53 Billion IDR | -0.36% |
| 2023 Q2 | 743.58 Billion IDR | -0.53% |
| 2023 FY | 830.4 Billion IDR | 10.69% |
| 2023 Q3 | 839.74 Billion IDR | 12.93% |
| 2022 Q2 | 752.78 Billion IDR | -0.4% |
| 2022 FY | 750.23 Billion IDR | 106.79% |
| 2022 Q4 | 750.23 Billion IDR | -0.12% |
| 2022 Q1 | 755.82 Billion IDR | 108.33% |
| 2022 Q3 | 751.1 Billion IDR | -0.22% |
| 2021 Q3 | 312.35 Billion IDR | 2.4% |
| 2021 Q2 | 305.04 Billion IDR | 0.05% |
| 2021 Q1 | 304.89 Billion IDR | 3707.42% |
| 2021 FY | 362.8 Billion IDR | 4430.54% |
| 2021 Q4 | 362.8 Billion IDR | 16.15% |
| 2020 Q1 | 6.92 Billion IDR | 13.99% |
| 2020 FY | 8 Billion IDR | 31.84% |
| 2020 Q4 | 8 Billion IDR | 13.14% |
| 2020 Q3 | 7.07 Billion IDR | -5.93% |
| 2020 Q2 | 7.52 Billion IDR | 8.67% |
| 2019 Q3 | 8.55 Billion IDR | 18.18% |
| 2019 Q4 | 6.07 Billion IDR | -29.02% |
| 2019 Q2 | 7.24 Billion IDR | 4.47% |
| 2019 FY | 6.07 Billion IDR | -9.01% |
| 2019 Q1 | 6.93 Billion IDR | 3.82% |
| 2018 Q1 | 739.87 Million IDR | 44.45% |
| 2018 FY | 6.67 Billion IDR | 1203.32% |
| 2018 Q4 | 6.67 Billion IDR | -24.29% |
| 2018 Q3 | 8.81 Billion IDR | 6.84% |
| 2018 Q2 | 8.25 Billion IDR | 1015.5% |
| 2017 FY | 512.19 Million IDR | -40.19% |
| 2017 Q2 | 1.13 Billion IDR | 11.31% |
| 2017 Q1 | 1.02 Billion IDR | 19.17% |
| 2017 Q3 | 543.55 Million IDR | -52.15% |
| 2017 Q4 | 512.19 Million IDR | -5.77% |
| 2016 Q3 | 4.87 Billion IDR | 7.04% |
| 2016 Q1 | 4.38 Billion IDR | 6.62% |
| 2016 FY | 856.4 Million IDR | -79.17% |
| 2016 Q4 | 856.4 Million IDR | -82.43% |
| 2016 Q2 | 4.55 Billion IDR | 3.84% |
| 2015 Q3 | 11.43 Billion IDR | 0.0% |
| 2015 FY | 4.11 Billion IDR | -62.8% |
| 2015 Q1 | 11.13 Billion IDR | 0.69% |
| 2015 Q2 | 11.43 Billion IDR | 2.77% |
| 2015 Q4 | 4.11 Billion IDR | -64.05% |
| 2014 Q4 | 11.05 Billion IDR | -28.73% |
| 2014 FY | 11.05 Billion IDR | -39.34% |
| 2014 Q3 | 15.51 Billion IDR | -17.29% |
| 2014 Q2 | 18.75 Billion IDR | 0.0% |
| 2014 Q1 | 18.75 Billion IDR | 2.91% |
| 2013 FY | 18.22 Billion IDR | 144.27% |
| 2013 Q2 | 26.71 Billion IDR | 57.37% |
| 2013 Q3 | 26.86 Billion IDR | 0.58% |
| 2013 Q4 | 18.22 Billion IDR | -32.18% |
| 2013 Q1 | 16.97 Billion IDR | 127.56% |
| 2012 Q1 | 1.09 Billion IDR | -20.53% |
| 2012 FY | 7.45 Billion IDR | 441.67% |
| 2012 Q2 | 5.72 Billion IDR | 423.15% |
| 2012 Q3 | 10.48 Billion IDR | 83.14% |
| 2012 Q4 | 7.45 Billion IDR | -28.86% |
| 2011 Q4 | 1.37 Billion IDR | 0.0% |
| 2011 FY | 1.37 Billion IDR | 202.55% |
| 2010 FY | 455.18 Million IDR | 329.71% |
| 2009 FY | 105.92 Million IDR | 197.87% |
| 2008 FY | 35.56 Million IDR | -96.24% |
| 2007 FY | 947.03 Million IDR | -44.88% |
| 2006 FY | 1.71 Billion IDR | 267.22% |
| 2005 FY | 467.88 Million IDR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 1.04 Billion IDR | -79458.938% |
| PT Merck Tbk | 11.19 Billion IDR | -7317.128% |
| PT Phapros, Tbk | 162.65 Billion IDR | -410.519% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3.3 Billion IDR | -25063.889% |
| PT Tempo Scan Pacific Tbk | 70.73 Billion IDR | -1074.02% |